Tigermed reports stable share capital for september 2025

Hangzhou Tigermed Consulting Co., Ltd. submitted its monthly return of changes in securities for the period ended September 30, 2025, to the Hong Kong Exchanges and Clearing Limited. The report, filed on October 8, 2025, confirms no changes in the company's issued share capital or treasury shares during the reporting month.

The company's statutory/registered share capital for A shares remained at 737,901,250 yuan with a par value of 1 yuan per share. Its H shares maintained a statutory/registered share capital of 123,124,800 yuan, also with a par value of 1 yuan per share. The total statutory/registered share capital at the end of the month amounted to 861,026,050 yuan.

Regarding issued shares, A shares recorded 732,017,470 issued shares (excluding treasury shares) and 5,883,780 treasury shares, totaling 737,901,250 shares. H shares had 123,124,800 issued shares and no treasury shares. The company noted past buybacks of A shares from May 2024 to February 2025, with 3,922,520 treasury shares cancelled on May 29, 2025, leaving 5,883,780 A shares as treasury shares as of September 30, 2025.